The risk of zoonotic infection and ensuing limited chains of infection, however, remains because of the enormous viral reservoir in dromedary camels, especially across the Arabic Peninsula and parts of eastern and northern Africa [8, 9]

The risk of zoonotic infection and ensuing limited chains of infection, however, remains because of the enormous viral reservoir in dromedary camels, especially across the Arabic Peninsula and parts of eastern and northern Africa [8, 9]. a separate window Fig. 3 Structural organization of coronavirus particle and the spike protein?S. a?Schematic of virus particle. b?Ribbon diagrams of the soluble?S protein trimer. The three monomers are colored in in the em right panel /em In 2002, the emergence of SARS-CoV?1 in China and its global spread caused a?first coronavirus-related human health crisis of international concern [5]. It became rapidly clear that this virus had jumped to humans from natural reservoirs in bats, likely through intermediate hosts such as civet cats [3]. Fortunately, human-to-human transmission could be interrupted completely by hygienic measures HDACs/mTOR Inhibitor 1 of epidemic control within a?short period of time, and natural transmission of the virus came to an end by 2003 [6]. A?second potentially deadly human coronavirus (Middle East respiratory syndrome coronavirus, MERS-CoV) emerged in 2012 in Saudi Arabia HDACs/mTOR Inhibitor 1 [7]. In this case, the source of transmission to humans was identified as infected dromedary camels. Although human-to-human transmission chains occurred and still do occur, they can be contained and do not result in widespread outbreaks. The risk of zoonotic infection and ensuing limited chains of infection, however, remains because of the enormous viral reservoir in dromedary camels, especially across the Arabic Peninsula and parts of eastern and northern Africa [8, 9]. Both SARS?1 and MERS viruses are betacoronaviruses but belong to two different genetic lineages, B and C, respectively, distinct from lineage?A which comprises HCoV-OC43 and HCoV-HKU1 (Fig.?1; [2]). After the emergence of SARS-CoV?1, efforts to identify natural reservoirs provided ample evidence for extensive circulation of SARS-like coronaviruses in bats with the potential of crossing species barriers and the emergence in humans [10, 11]. Corresponding publications were full of warnings that SARS-1-like emergences could happen again, unless contact to the natural reservoir of coronaviruses in bats and transmission to humans via intermediate hosts cannot be properly controlled [5]. Unfortunately, these warnings did not materialize in practice, and a?very similar virus (now called SARS-CoV-2) emerged at the end of 2019 in Wuhan, China. From there, the virus rapidly spread globally and to date (25 October 2020) the pandemic has caused 43,341,451 documented cases of infection and 1,157,509 fatalities/deaths [12]. Genome and virion structure The genome of SARS-CoV?2 is ~29,800 nucleotides in length [13] and has the characteristic features of coronaviruses in general (Fig.?2). They all have exceptionally large nonsegmented positive-stranded RNA genomes (ranging between ~26,000 and 32,000 bases [2]), which contain 3 sets of open reading frames (ORF) encoding three groups of proteins with different functions: 1.?16 non-structural proteins (nsp1 to nsp16) that include the viral RNA polymerase, proteases and other virus-specific enzymes involved in virus replication. 2.?The structural proteins?S (spike), E (envelope), M (membrane), and N (nucleocapsid) that are essential building blocks of virus particles (Fig.?3a) (some coronaviruses, e.g. HCoV-OC43 have a?hemagglutinin-esterase protein as an additional structural component [2]). 3.?A?variable number of ORFs interspersed with the genes for structural proteins, encoding proteins that are produced in infected cells but are not essential for fundamental virus replication. These accessory genes can differ in quantity and sequence actually among closely related coronaviruses and apparently contribute to the tuning of virus-host cell relationships to produce an ideal environment for disease replication and transmission, e.g. by counteracting innate antiviral sponsor reactions [14]. The genetic mutation rate of SARS-CoV?2 and coronaviruses in general is lower than that of additional RNA viruses due to a?proofreading activity in the viral RNA replication machinery [15, 16]. However, coronavirus genomes have a?high degree of plasticity and mechanisms that allow quick virus evolution. These include a?propensity for recombination (leading to the exchange of whole gene segments among different coronaviruses during two times infections of the same cell in the same host) as well as the capacity for acquisition and deficits of accessory protein coding genes, facilitating adaptive changes in addition to mutation [2]. Together with the structural flexibility of the spike protein, allowing adaptation to different cellular receptors with relative simplicity, these properties are the basis for the propensity of coronaviruses for crossing varieties barriers and jumping hosts. The SARS-CoV?2 disease HDACs/mTOR Inhibitor 1 particle has the typical coronavirus morphology, having a?diameter of ~80C120?nm [17]. Infectious virions are composed of a?helical nucleocapsid (comprising the genomic RNA and multiple copies of the N?protein) and a?lipid envelope with three membrane-associated proteins, M (membrane), E (envelope), and S, forming the characteristic club-shaped projections in the viral surface (Fig.?3a). The spike protein has attracted unique attention, because it provides the essential viral functions for cell access (receptor binding and membrane fusion) and is the main target of neutralizing and potentially protecting antibodies [18]. It is therefore considered the most important and essential antigen component of vaccines (observe section Potential customers for vaccines). Rabbit polyclonal to ANGPTL3 Each of the spikes is composed of three S?protein subunits, and.